Selectivity determining features in N-myristoyltransferases – a model system for drug targets with conserved binding sites
Loading...
Files
Date issued
Authors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Reuse License
Abstract
In rational drug design projects one major goal is to obtain high affinity ligands for a target, while maintaining selectivity over potential off-targets and thereby reducing unwanted side effects. However, this proves to be challenging when facing highly conserved binding sites. In this project, the focus was laid on a model system of two well investigated essential eukaryotic enzymes, which catalyze the transfer of myristate to a various number of substrates – the N-myristoyltransferases (NMT) of Leishmania major (LmNMT) and the human homologue HsNMT1. The enzymes share an overall sequence identity of over 40 % and an identical first protein-ligand interaction shell. Many non-selective NMT-inhibitors were found previously, but only a few selective ones are known. Further, the molecular basis for selective inhibition was unclear. A combination of molecular dynamic simulations (MDs), isothermal titration calorimetry (ITC), fluorescence-based enzyme inhibition assay and X-ray crystallography was used to analyze protein dynamics, water network formation and their changes upon ligand binding. Two different selectivity determining features were identified and validated by site-directed mutagenesis – the impairment of protein flexibility upon ligand binding close to the catalytically active C-terminus and a highly stable water molecule, only present in the binding site of HsNMT1. Based on these findings, a virtual screening was conducted and three novel and selective LmNMT inhibitors were revealed.